Shares of Novavax Inc. NVAX slipped 1.69% to $8.13 Friday, on what proved to be an all-around poor trading session for the ...
The stock's fall snapped a two-day winning streak.
Dynavax should take a leaf from its vaccine maker peer, Novavax, and work to monetize its CpG1018 adjuvant. Learn more about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback